ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p425.xmlPolitics as Usual—Not!2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p425.pdf2026-04-18Politics as Usual—Not!https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-pxxxvii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-pxxxvii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-pliv.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-pliv.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p433.xmlNCCN Guidelines Insights: Breast Cancer, Version 1.20172026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p433.pdf2026-04-18NCCN Guidelines Insights: Breast Cancer, Version 1.2017https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p457.xmlInfusion-Compatible Antibiotic Formulations for Rapid Administration to Improve Outcomes in Cancer Outpatients With Severe Sepsis and Septic Shock: The Sepsis STAT Pack2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p457.pdf2026-04-18Infusion-Compatible Antibiotic Formulations for Rapid Administration to Improve Outcomes in Cancer Outpatients With Severe Sepsis and Septic Shock: The Sepsis STAT Packhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p466.xmlTrends in the Incidence and Outcomes of Hospitalized Cancer Patients With Clostridium difficile Infection: A Nationwide Analysis2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p466.pdf2026-04-18Trends in the Incidence and Outcomes of Hospitalized Cancer Patients With Clostridium difficile Infection: A Nationwide Analysishttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p427.xmlTherapeutic Response of Metastatic Colorectal Cancer Harboring a KRAS Missense Mutation After Combination Chemotherapy With the EGFR Inhibitor Panitumumab2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p427.pdf2026-04-18Therapeutic Response of Metastatic Colorectal Cancer Harboring a KRAS Missense Mutation After Combination Chemotherapy With the EGFR Inhibitor Panitumumabhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p504.xmlNon–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p504.pdf2026-04-18Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p545.xmlWhy a One Size Fits All Approach to RAS Might Not Fit Colorectal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p545.pdf2026-04-18Why a One Size Fits All Approach to RAS Might Not Fit Colorectal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p473.xmlRegional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p473.pdf2026-04-18Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanomahttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p484.xmlPaving the Way for Dose Banding of Chemotherapy: An Analytical Approach2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p484.pdf2026-04-18Paving the Way for Dose Banding of Chemotherapy: An Analytical Approachhttps://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p494.xmlThe 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p494.pdf2026-04-18The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p537.xmlImplementation of Systemic Hedgehog Inhibitors in Daily Practice as Neoadjuvant Therapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/15/4/article-p537.pdf2026-04-18Implementation of Systemic Hedgehog Inhibitors in Daily Practice as Neoadjuvant Therapy